Delivery Order SPE2DB25D3306-SPE2DB25FUANH

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX7ZG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,474.62, is a Firm Fixed Price Delivery Order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF8T1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $3,441.70. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award is for the procurement of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML, which was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,459.68, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a delivery order type contract with a firm fixed price pricing structure. The contract has an ultimate completion date of March 28, 2024....
This federal contract award, identified as SPE2DB20D3103|SPE2DB24FN6L7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $10,199.21, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $11,537.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of May 31, 2024. This is a firm-fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY5KG, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,995.51 and a completion date of April 25, 2024. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $13,279.06, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Firm Fixed Price Delivery Order for the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal...
The federal contract award is for the delivery of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,592.62 and an ultimate completion date of October 31, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order valued at $7,043.14 with a completion date of January 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with the ID SPE2DB20D1004|SPE2DB24FF0A0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,991.24 firm fixed-price delivery order is for the supply of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUANH
    Delivery Order

This federal contract award, with ID SPE2DB25D3306|SPE2DB25FUANH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, with a total ceiling value of $3,201.38 and a completion date of January 13, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA Troop Support Medical. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:18 AM